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ABSTRACT 
HYDRODYNAMIC EFFECTS OF AN ARCH-SHAPED FIBER OPTIC PROBE 
IN A DISSOLUTION TESTING APPARATUS 2 
by 
Yiran Zhang 
Dissolution testing is widely used in the pharmaceutical industry to evaluate newly 
developed drug formulations and as a quality control method to insure that solid dosage 
forms have consistent dissolution property.  Typically, samples are manually drawn from 
the dissolution vessel prior to analysis.  An approach to overcome the limitations of 
manual sampling consists in the use of sampling probes, such as fiber optic probes, 
permanently inserted in the dissolution medium and continually sampling the drug 
concentration in it as the solid dosage form dissolves.  Despite their advantages, 
permanently inserted fiber optic probes can alter the normal fluid flow within the vessel 
and produce different dissolution testing results. 
In this study, the hydrodynamic effects introduced by an arch-shaped fiber optic 
probe in a USP Dissolution Testing Apparatus 2 are studied by: (1) conducting 
dissolution tests, with and without the probe, using Prednisone tablets fixed at nine 
different locations at the bottom of the vessel and comparing the dissolution profiles 
obtained using statistical tools; and (2) experimentally determining the velocity profiles 
in the vessel, with and without the probe, using Particle Image Velocimetry (PIV) and 
quantifying changes in the flow velocities on selected horizontal iso-surfaces.  
The results show that the arch shaped fiber optic probe does have a baffling effect 
on the hydrodynamics in the dissolution vessel.  This effect results in changes in the 
velocities in the fluid flow, and therefore in changes in the dissolution rate of the tablets 
undergoing testing.  The baffle effect is observed mainly in the region where the probe is 
 
 
inserted.  However, this perturbation is also found to reach the region below the impeller 
and to change the velocity profile there, resulting in differences in dissolution profiles 
when the tablets are fixed at positions that are downstream of the probe and within the 
low velocity region below the impeller.   
On the other hand, the hydrodynamic effect generated by the probe does not 
appear to be particularly strong. In most dissolution testing runs, the changes in 
dissolution profile are not large enough to fail the tests, according to the FDA criteria (f1 
and f2 values).  The PIV measurements additionally show that the baffle effect is not 
strong enough to break the overall flow pattern, or to affect the region around the 
impeller, which is dominated by the main flow generated by the impeller.  
It can be concluded that the hydrodynamic effects generated by the arch-shaped 
fiber optic probe are real and observable, resulting in slightly modification of the fluid 
flow in the dissolution vessel and therefore in detectable differences in the dissolution 
profiles.  However, these effects are limited and do not typically lead to dissolution 
testing failures. 
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CHAPTER 1  
INTRODUCTION 
1.1 Background 
Dissolution testing is widely used in the pharmaceutical industry, both as a tool to 
evaluate, in vitro, newly developed solid formulations, and as a quality control technique 
to insure that the manufactured tablets/capsules have consistent dissolution property. The 
USP Dissolution Testing Apparatus 2 is the device most commonly used in dissolution 
testing for oral dosage forms. Typically, dissolution testing consists of dropping the 
dosage form in the dissolution vessel containing the dissolution medium, stirred by a 
paddle, manually removing liquid samples over time, and then bringing the samples 
either to a UV spectrometer for determination of the analytic concentration, or to a HPLC 
for UV or fluorescence detection after separation. This manual operation has a number of 
disadvantages: 
1. Labor intensiveness. At least one trained individual is needed to take samples 
over the whole testing period, and extra time is needed to analyze the samples 
afterwards. 
2. Operator’s errors. The operator has to carefully follow standard operating 
procedure (SOP) to avoid introducing errors. Still human errors cannot be totally 
eliminated.  
3. Limited dissolution data. Usually less than 10 samples are taken over the whole 
testing period. The drug release curve cannot be plotted smoothly based on such 
small number of data points.  
An approach to overcome the limitations of manual sampling consists in the use of 
sampling probes permanently inserted in the dissolution medium and continually 
sampling the drug concentration in it as the solid dosage form dissolves.  Fiber optic 






probes in dissolution testing has been studied in past decades since early study was done 
by Josefson (1988). The application was considered to be able to change the traditional 
way of sampling and overcome the disadvantages mentioned above (Liu, et al., 2008). 
Labor intensiveness can be significantly reduced by eliminating manual sampling and 
analyzing procedure. Accuracy and consistency of data are increased by eliminating 
operator’s errors and analyst-to-analyst variation. A real-time drug release level can be 
determined in-situ or in the vessels without sample removal. Many more data points can 
be collected and more accurate dissolution profiles can be generated than with manual 
sampling.  
Despite of all these advantages, the use of fiber optic probes also has limitations. 
One of them is the effect to hydrodynamics in the dissolution vessel. The presence of any 
permanently inserted probe can alter, in principle, the normal fluid flow within the vessel. 
Although the probe is typically small, it can act as a baffle in a perfectly symmetrical 
system. This loss of symmetry, and the introduction of the probe, which acts as a small 
baffle, can result in changes in velocity profile and shear rates, which can cause 
variations in dissolution testing results when compared to system that do not incorporate 
such as device. Therefore, research has been conducted to validate this technique to 
insure that it is compliant with regulatory requirements (Gary, 2003; Mirza, et al., 2009). 
Possible changes in the dissolution performance variation should be studied carefully 
before replacing the current methodology with this technique. 
Being a relatively new technology in dissolution testing, no standards exist for 
fiber optic probes. In addition, there are different types of probes, and this adds 






vessel, fiber optic probes can be categorized into three types, as shown Figure 1.1: 1) 
shaft probes, which are fixed in a hollow shaft and placed at the center of the vessel; 2) 
rod probes, essentially a solid rod dipped in the vessel with a detection window in the 
traditional sampling location defined by United States Pharmacopeia (USP); and 3) arch-
shaped probes, which have an arch shape and a detection gap at the bottom of the probe 
located at the traditional USP sampling location (Lu et al., 2003). UV light is able to get 
into the dissolution medium from one side of the gap and travels to the other side. 
Therefore light absorption data can be obtained. This system also has other advantages, 
such as small displacement volume, simple light path, and reduced bubble and particulate 
accumulation (Inman et al., 2001). In this study, an arch-shaped probe was used to be 
tested in the USP Dissolution Apparatus 2 to determine possible changes in the flow 
pattern introduced by the presence of the probe. 
 
Figure 1.1  Three types of UV Fiber Optic Probes.(Lu et al., 2003) 
 
The USP Dissolution Apparatus 2 has been widely used in the pharmaceutical 






(Cohen et al., 1990). However, previous studies done by Baxter et al. (2005) and Bai et al. 
(2007) have shown that as a small unbaffled vessel with hemispherical bottom, this 
apparatus is associated with complex hydrodynamic conditions. As a perfectly 
symmetrical mixing system, the USP Apparatues 2 is very sensitive to any deviation from 
symmetry, such as the introduction of the arch shaped fiber optic probe.  
A literature review of studies on hydrodynamic effect of fiber optic probes 
showed that investigation has been done by several groups. Schatz et al. (2000) reported 
no significant difference in dissolution result using shaft probe. Martin (2003) and Lu et 
al. (2003) reported noticeable difference using rod probe, and Inman et al. (2001), Inman 
(2003), and Lu et al. (2003) all reported minimal or small difference using the arch-
shaped probe. However, these studies on arch shaped probes were limited by limited 
amount of data and lack of a more sophisticated experimental methodology.  
1.2 Objectives of This Work 
Therefore, the overall objective of this study was to quantify the hydrodynamic effects of 
the arch shaped fiber optic probe in USP Dissolution Testing Apparatus 2. To do so, two 
different methodologies were used in this study. In order to study solely the 
hydrodynamic changes introduced by the arch-shaped probe and its effect on the 
dissolution profiles, efforts were made to eliminate any other factors that could also affect 
the test results. As shown in previous study on the USP Dissolution Apparatus 2 (Bai et 
al., 2007), the exact location of the dissolving tablet introduces significant variations in 
the flow and in the shear stress experienced by the tablet, which, in turn, can affect the 






were conducted in the presence and in the absence of the arch-shaped fiber optic probe 
using tablets fixed in place at 9 different locations at the bottom of the USP Apparatus 2 
dissolution vessel, i.e., with tablets located 10° or 20° off-center and at different positions 
with respect to the probe. Statistical tools were then used to evaluate and compare the 
results at each tablet position. 
In addition, in order to find the root cause of possible hydrodynamic effects of the 
probe on the dissolution profiles, velocity measurements were made under different 
conditions using Particle Image Velocimetry (PIV).  PIV was used to visualize and 
quantify the flow velocity field in the vessel. This approach also allowed a comparison to 
be made between changes in the dissolution profiles and variations in the flow field that 





CHAPTER 2  
EXPERIMENTAL APPARATUS, MATERIALS AND METHODS 
2.1 Dissolution Tests 
2.1.1 Dissolution Apparatus 
Dissolution testing experiments were conducted in a USP Dissolution Testing Apparatus 
2. The dissolution test system was a Distek 5100 Bathless Dissolution Apparatus (Figure 
2.1a) from Distek Inc., North Brunswick, NJ. The agitation system was a two-blade 
paddle impeller mounted on a shaft and connected to the motor in the Distek system. 
Unbaffled, cylindrical, hemisphere-bottomed glass vessels with maximum capacity of 1 L 
were used as the dissolution vessels. In the standard system, the vessel was covered by a 
plastic vessel lid with two openings for sampling. The agitation system, the vessel and the 
lid are shown in Figure 2.1b. 
              
(a)       (b) 
Figure 2.1  (a) Distek 5100 Bathless Dissolution Apparatus (b) USP Dissolution Testing 






The dimensions of the vessel and the impeller were measured by a caliper, and 
were found to be as follows: vessel internal diameter, 100.16 mm; shaft diameter, 9.52 
mm; length of the top edge of the blade, 74.10 mm; length of the bottom edge of the 
blade, 42.00 mm; height of the blade, 19.00 mm; and thickness of the blade, 4.00 mm. 
The impeller clearance off the vessel bottom was 25 mm, as mandated by the USP (2008). 
When the vessel was filled with 500 mL of dissolution media, the corresponding liquid 
height, as measured from the bottom of the vessel, was 78.6 mm. The geometry of the 
vessel with the probe and the agitation system in place and containing 500 mL of 
dissolution media is shown in Figure 2.2.  
The fiber optic sampling probe tested in this study was an arch shaped metal 
probe provided by the Merck Company.  The probe consisted of two sections of a thin 
(0.8 mm) vertical tubing bent at their bottom to bring their ends near each other 
horizontally so that they were separated by a small gap (2 mm), as shown in Figure 2.3.  
The two pieces of tubing were kept in position by two horizontal metal braces.  The fiber 
optic cable ran inside the tubing. Although not used for this purpose in this work, the 
probe is intended to measure the light attenuation as a light beam travels in the gap when 
the probe was inserted in a the medium in which a tablet is dissolving. When connected 
to UV spectrometer, UV light would go through the detecting gap and get partially 
absorbed by the dissolution solution. Therefore the UV absorbance data of the solution 
can be obtained continuously. The figure also shows the specially made plastic vessel lid 
with a long slot that was used to support the probe and keep it in place. Additional 
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Figure 2.2  (b) Bottom view of USP Dissolution Testing Apparatus 2 vessel (Continued). 
 
 







Figure 2.4  Dimensions of arch fiber optic probe. 
 
As specified in the USP, liquid samples taking manually during a dissolution test 
should be taken within a required zone in the dissolution medium, i.e., horizontally 
midway between the impeller shaft and the vessel wall, and vertically midway between 
the top edge of the impeller and the surface of the dissolution medium. In the case of the 
fiber optic probe, the detecting gap at the bottom of the probe was where the samples 
should be taken. Therefore, the probe would be installed properly so that the detecting 





gap stays in the sampling zone during dissolution tests. The detailed location of the probe 
after its installation in the vessel is shown in Figure 2.5. 
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Figure 2.5  (c) Bottom view of the probe in dissolution testing vessel (Continued). 
 
In this work, a 10 mL syringe and 2 mm cannula were used to take samples 
manually from dissolution testing solution, also a disposable PVDF 0.45 µm filter was 
attached to remove possible solid particles that could have entered the sample. A 
spectrophotometer (Cole Parmer S2100UV+) was used to obtain UV absorption data 
from the samples. 
2.1.2 Dissolution Test Materials 
Disintegrating tablets, i.e., 10 mg Prednisone tablets (NCDA #2), kindly donated by Dr. 
Zongming Gao, Food and Drug Administration (FDA), Division of Pharmaceutical 
Analysis, Center for Drug Evaluation and Research, St. Louis, MO, were used in this 





acrylic glue was used to fix the tablet at a particular location on the bottom of the 
dissolution vessel. 
The medium used for dissolution tests was de-aerated distilled water. The medium 
was de-aerated before using, according to the method developed by Moore (1996) 
following the USP requirement (USP, 2008) (Figure 2.6). Accordingly, the medium was 
placed in carboy tank, which was then connected to a vacuum pump. Vacuum was 
applied for 30 minutes while all other valves in the system were closed. This stock 
solution was used as needed (typically in 500 mL aliquots per test).  
 
Figure 2.6  Setup of de-aeration process for dissolution medium. (USP, 2008) 
2.1.3 Dissolution Test Method 
The procedure for the dissolution test was based on the USP requirement (USP, 2008). 
However changes were made due to the fact that the tablets were fixed on the bottom of 
the vessel, instead of being dropped into the medium. 
In each side-by-side experiment, two tablets were tested simultaneously using 
different setup of apparatus, i.e., the testing system with the fiber optic probe inserted, 
and standard system without the probe. The effect of minor geometrical variations 





The tablets were attached at the same predefined position on the vessel bottom 
with a very small bead of commercial glue before the experiment starts. Since the testing 
system was non-symmetrical, nine positions on the vessel bottom were examined, as 
shown in Figure 2.7(a). Position 1 in this figure represents the center of the vessel bottom. 
Positions 2-5 were on an inner circle 10° off-center from the vessel vertical centerline.  
Positions 6-9, were on an outer circle 20° off-center from the vessel vertical centerline 
(Figure 2.6(b)). These angles were taken from the center of the sphere comprising the 
hemispherical vessel bottom, and measured starting from the vertical centerline to the 
point of interest, (e.g., the angle would be zero for the central point below the impeller). 
These positions were spaced 90° apart from each other. As for standard system, though it 
is symmetrical, data from nine points were obtained to pair with the data from the testing 
system. For each point, three runs were performed at different times. 











Figure 2.7  (a) Top view of the bottom of the dissolution vessel with nine different tablet 







Figure 2.7  (b) The front view of the dissolution vessel with three different tablet 
positions (0°, 10°, 20°) in standard system (Continued).  
 
Before each experiment, all key geometrical measurements were checked 
(impeller clearance, impeller position, etc.). After the vessels with the attached tablets 
were properly placed in the Distek system, 500 mL de-aerated distilled water, previously 
preheated to 37.5 
o
C, were poured gently to each of the two vessels. A plastic funnel was 
used to keep water running down along the wall in order to minimize gas introduction 
and dissolution of the tablet before the test started. The agitation, previously set at 50 rpm, 
was turned on immediately after pouring the dissolution medium, the probe was inserted 
to its predefined place in the testing system, and a stopwatch was started simultaneously. 
The first pair of samples was taken immediately after starting the agitation. These 
samples were defined as the samples of time t=0. The time interval between samples was 





The temperature was maintained at 37
 o
C throughout the whole experiment by the 
temperature controller built in the Distek system.  
In order to keep the results from the two systems comparable, the same 
conventional sampling procedure was used in both systems, in despite of the fact that the 
fiber optic probe was able to take samples continuously. Samples were taken by 
removing 10 mL aliquots by the combination of syringe, filter and cannula. The volume 
of medium removed by sampling was not replaced, in accordance to the USP procedure 
(USP, 2008). The sampling position was within the USP specified sampling zone, i.e., 
horizontally located midway between the impeller shaft and the vessel wall, and 
vertically midway between the top edge of the impeller and the surface of the dissolution 
medium. The initial 2 ml of each sample was discarded, and the remaining was moved to 
a sample vial for further analysis.  
Analysis of samples was carried out using 1 cm quartz cells placed in a UV 
spectrophotometer measuring absorbance at USP specified wavelength, i.e., 242 nm for 
Prednisone (the approximate wavelength of maximum absorbance). A blank data was 
taken for reference, by measuring the absorbance of only the dissolution medium, i.e., de-
aerated distilled water. Before putting the sample solution into the quartz cell, the cell 
was rinsed with the same solution twice.  
The absorbance data was converted to concentration of Prednisone by a calibrated 
absorbance vs. concentration curve for Prednisone. To plot the calibration curve, a series 
of standard solutions of Prednisone was made by fully dissolving a Prednisone tablet (10 
mg) into the dissolution medium, and diluting with a known volume of distilled water. 





regression was performed to establish the conversion from UV absorbance to Prednisone 
concentration.  
Additional details of the operating conditions are presented in Table 2.1.   
Table 2.1  Operating Conditions for Dissolution Experiments with Prednisone Tablets 
Dose 10 mg 




Agitation Speed 50 rpm 
Filter PVDF 0.45 µm 
UV Wavelength (UV Spectroscopy) 242 nm 
Standard Tablets Calibrated Tablets 
Time 5 min sampling interval; 45 min total 
Sample Volume 10 ml 
Sample Replacement  No 
 
2.1.4 Dissolution Test Data Analysis 
The UV absorbance data obtained was first converted to Prednisone concentration 
at certain time, (Cn, mg/ml). Since samples were removed without replacing their 
volumes, the drug release ratio (mD/mT), i.e. the amount of drug in solution at any time t 
out of the total initial amount of drug in the tablet was calculated using the following 
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  (2.1) 
 
Where  D nm t  is the mass of dissolved Prednisone at time n, Tm is the label 
claimed mass of the tablet, Cn is the Prednisone concentration in the sample at time tn, C* 
is the concentration of Prednisone tablet fully dissolved into 500ml dissolution medium, 
V is the initial volume of dissolution medium (500 ml), ΔV is the volume of each sample 
(10 ml). The detailed derivation of Equation 2.1 is shown in Appendix A.  
Since a sample was initially taken at t= 0 (zeroth sample). So the 10th sample in 
the dissolution test (including the initial one) corresponded to n=9 (not n=10), i.e., n=0, 1, 
2, 3, 4, 5, 6, 7, 8, and 9 (10 samples taken every 5 minutes, starting at time t=to=0 min, 
and ending at time t9=45 minutes). 
The dissolution profiles for each experiment obtained with the testing system 
were compared to the profile from its paired standard system in order to determine 
whether these dissolution curves were statistically similar to each other. These drug 
release data was plotted against time (min) and evaluated by the following methods. 
A paired Student’s t-test was used to obtain the probability of the null hypothesis 
that the two sets of data came from the same underlying population, i.e., that the 
probability the dissolution profiles from the two systems were statistically the same. The 
equations for the paired Student’s t-test are  
 
  
(  ̅̅ ̅̅    )







𝐷𝐹= −1 (2.3) 
 
where   ̅̅ ̅̅  is the sample mean (in this case the average of the differences between 
curves),    the population mean (in this case the constant from which to test whether the 
average of the difference is different, i.e.,   =0 here),    is the sample standard deviation 
(in this case the standard deviation of the differences between curves), DF is degree of 
freedom and n is sample size. Once a t and DF is determined, the probability (T-value) 
can be found using a table of values from Student's t-distribution (Dunnett and Sobel, 
1954) 
The significant level was chosen to be 0.05, i.e., if the T-value obtained was 
smaller than 0.05, the null hypothesis was rejected; the two groups of data were 
considered statistically from different systems. 
In addition, to quantify the similarity/difference of two groups of dissolution 
profiles, the FDA-recommended approach was used. This approach consists of using two 
model-independent methods based on the similarity factor (f1) and difference factor (f2) 






































f  (2.5) 
 
where Rt is the reference assay at time t, i.e., the results from the standard system. 
Τt is the test assay at the same time, i.e., the paired results from the testing system, and n 
is the number of points. The f1 factor measures the percent error between two curves for 
all points. The percent error is zero when the test and reference profiles are identical, but 
increases proportionally with the dissimilarity between the two dissolution profiles. The 
higher the similarity factor f1 (which can be in the range of 0 to 100), the higher the 
average difference between reference and test curves is. The f2 factor is a logarithmic 
transformation of the sum-squared error of differences between the test and the reference 
dissolution profiles over all time points (which can be in the range -α to 100).  If this 
difference is higher than 100, normalization of the data is required. The higher the 
difference factor f2, the lower the average difference between reference and test curves 
(Costa and Lobo, 2001). Public standards have been set by FDA for f1 and f2. 
Accordingly, statistical similarity between the two curves being compared requires that 
both 0<f1<15 and 50<f2<100 (FDA, 1997; Baxter et al., 2005). 
2.2 Particle Image Velocimetry (PIV) 
2.2.1 PIV Apparatus 
A Dantec FlowMap 1500 2D Particle Image Velocimetry (PIV) apparatus (Dantec 
Dynamics A/S, Tonsbakken 16 – 18, DK – 2740 Skovlunde, Denmark) was used to 
determine the velocity flow field inside both testing system and standard system. The 






Figure 2.8  Schematic of laboratory PIV experimental set-up. 
 
The dissolution vessel used in the PIV experiment was placed in a Plexiglas tank 
filled with water in order to minimize refractive effects at the curved surface of the vessel 
wall. The agitation was provided by an electric motor connected to an external controller 
that kept it 50 rpm. The shaft and impeller in the experiment were specially made in 
black, in order to minimize the reflection of the laser light impinging on them.  
The light source of the PIV system was produced by a double pulsed 120 mJ Nd-
Yag laser (New Wave Research model Solo 120 15 Hz, Fremont, CA, USA), consisting 
of two infrared laser heads combined in a single package with a second harmonic 
generator and two discrete power supplies. The laser source came from a Class IV laser, 
which emitted 532 nm wavelengths light. The laser produced two pulsed infrared laser 
beams which passed through an optical arrangement of lenses to generate a laser light 
sheet. The laser light sheet was shot through the dissolution apparatus with seed particles 
in the medium. These particles were used to follow the fluid flow and scatter the laser 
light for fluid velocity measurements. In the experiments performed, the seed particles 





USA, Mahwah, NJ, USA) with a density of 1.4 g/cm3, sizes ranged from 2 to 20 μm, and 
mean particle size of 10 μm. The laser light scattered by these particles was captured by a 
digital camera (Dantec Dynamics HiSense PIV/PLIF camera model C4742-53-12NRB), 
which was installed perpendicularly against the laser light sheet. The digital camera 
contained a light filter to eliminate visible light and only capture the laser light. The laser 
and the digital camera were connected to a synchronizer (LASERPULSE Synchronizer, 
TSI model 610034), which was then in turn connected to a computer (DELL Precision 
WorkStation 530) for control and data analysis.  
All these components were controlled by dedicated software (FlowManager 4.71) 
which collected pairs of digitized images of illuminated particles in the dissolution 
apparatus from the CCD camera (with the two images in each pair being collected at a 
small but known time interval), which were subdivided into small subsections called 
interrogation areas. Each pair of frames for a given interrogation areas was then analyzed 
using cross-correlation to determine the spatial x- and y-displacement that maximized the 
cross-correlation function for that interrogation area. The resulting displacement vector 
obtained by dividing the x- and y- displacements by the time interval was taken as the 
fluid velocity in that interrogation area.  
2.2.2 PIV Method 
Both the testing system and the standard system were used in the PIV experiments. In 
each experiment, the velocity profiles on only one-half of top portion of the longitudinal 
section of the vessel could be determined since the laser light sheet was blocked by the 
shaft. Since the testing system (with probe inserted) was non-symmetrical, four 





Using the position numbering of tablets described in Figure 2.7(a), the four sections were 
named using the 10° and 20° tablet positions that lie on the section, i.e., Section 2-6 (i.e., 
the section intersecting tablet Positions 2 and 6), Section 3-7, Section 4-8, and Section 5-
9, as shown in Figure 2.9 (gray parts show the sections studied). 
In each PIV experiments, two pairs of images of the dissolution apparatus were 
taken at a time interval of 1 ms. 300 pairs in total were taken at a time interval of 600 ms 
between each pair. Image masks were defined and applied to all images to reject outside 
regions as well as the impeller and shaft regions of the apparatus in the image, in order to 
reduce the error in cross correlation. After the correlation was performed for every pair, 
the statistical average was taken out of the 300 pairs to obtain the velocity profile on the 
section under investigation. The profile then went through moving-range validation and 
average filter to obtain the final velocity vector map for further analysis. (FlowMap PIV 








                             Section 2-6           Section 3-7 
 
                             Section 4-8           Section 5-9 
Figure 2.9  Schematic of the four sections (in grey) studied using PIV. 
 
The liquid velocity at any point in the vessel has three components. The first 
velocity component is radial and acts in a direction perpendicular to the shaft of the 





The third component is tangential and acts in a direction tangent to a circular path around 
the shaft. In this study, only the axial and radial components were investigated.  
  
Figure 2.10  Nine iso-surfaces chosen for PIV measurements. 
 
To fully quantify the fluid flow in the dissolution apparatus, nine horizontal 





bottom of the vessel was defined as z=0 mm. Four iso-surfaces were chosen below the 
impeller (z=20mm, 15mm, 10mm and 5mm). Three were chosen in the impeller region: 
the top edge of the impeller, i.e., z=44mm, the middle of the impeller, i.e., z=35mm, and 
the bottom edge of the impeller, i.e., z=25mm. Two were chosen above the impeller, i.e., 
in the medium surface region, i.e., at z=75mm and at the bottom of the probe, i.e., at 
z=61mm. The radial and axial velocities on these iso-surfaces were extracted, plotted and 
analyzed. 
Sums of squared deviations were calculated to compare the velocity profiles on 
the four sections of the testing system to those of the standard system. The equation used 
for this purpose is: 
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where U is the velocity of the testing system and U0 is the corresponding velocity 
of the standard system at the same data point. By summing up all squared deviations in 
each of the three regions, i.e., below the impeller, around the impeller and above the 
impeller, as well as in the whole section, the hydrodynamic effect generated by the fiber 





CHAPTER 3  
RESULTS 
 
As discussed in Chapter 2, this study was focused on the quantification of the 
hydrodynamic effects introduced by the presence of a fiber optic probe in a USP 
Apparatus 2 by comparing the dissolution profiles obtained in the testing system and the 
standard system, and by visualizing the flow velocity vectors in the two systems using 
PIV measurements and quantitatively analyzing the velocities on nine iso-surfaces. 
3.1 Results of Dissolution Tests 
The dissolution profiles of Prednisone at nine different tablet positions (at 0°, 10° and 20°) 
in both systems were obtained following the method described in Section 2.1. The results 
were interpreted by plotting the drug release curve, i.e., the drug release ratio mD/mT 
against time (min), for all experimental run. The result were also interpreted by plotting 
the concentration ratio C(tn)/C*, i.e., the sample concentration at time n divided by fully 
dissolved concentration, against time (min). These results are shown in Appendix B. 
To eliminate the effect of other variations such as room temperature and humidity, 
the dissolution profiles of the testing system were only compared with their 
corresponding profiles of the standard system. Each individual run was studied separately 
without taken any average. Paired t-test (t), similarity factor (f1), and difference factor (f2) 





3.1.1 Calibration Results for Prednisone Tablets 
Calibration was performed following the method described in Chapter 2 Section 2.1.3. 
This process was initially performed twice to establish the conversion from UV 
absorbance to Prednisone concentration, and repeated every 3 months, without showing 
significant change.  The results are presented in Table 3.1 and Figure 3.1 for two sets of 
calibration experiments. 
Table 3.1  Calibration Data for Prednisone Tablets 
Concentration (mg/ml) Absorbance 1 Absorbance 2 Average Absorbance 
0.05 2 1.947 1.9735 
0.025 1.02 0.986 1.003 
0.0166 0.68 0.675 0.6775 
0.0125 0.536 0.506 0.521 
0.01 0.44 0.428 0.434 
0.005 0.253 0.243 0.248 
0.0033 0.187 0.182 0.1845 
0 0.055 0.055 0.055 
 
Figure 3.1  Calibration curve and regression for Prednisone tablets. 
y = 0.0261x - 0.0013 































The difference between the two set of absorbance data was minor, and the R value 
of the regression was 0.9999.  Therefore, a linear relation between UV absorbance and 
concentration was confirmed. The equation displayed in Figure 3.1 was used to obtain the 
concentration from absorbance data. 
3.1.2 Dissolution Profiles for Centrally Positioned Tablets (Position 1) 
The dissolution profiles for centrally positioned Prednisone tablets were obtained using 
both testing system and the standard system. The experiment with one testing system and 
one standard system running parallel was repeated three times. The results from these 
three runs are reported here in terms of drug release ratio mD/mT over time, and presented 
in Figure 3.2. The values of the Similarity Factor f1 and the Difference Factor f2 and the 
paired t-test T values were calculated as described in Section 2.4 and are presented in 
Table 3.2. The detailed data obtained in this study are shown in Tables C.1, C.2 and C.3 
in Appendix C.  
The difference between the dissolution profiles for the testing system and the 
standard system could be easily recognized: the testing system, with the fiber optic probe 
immersed in the liquid over the entire testing period, generated higher concentrations 
than the standard system in all three runs. The results of paired t-test showed that the T-
values, i.e., the probabilities of the profiles being the same, were lower than the 
significant level of 0.05. On the other hand, the f1 and f2 values, quantifying the 
significance of similarity/difference of the dissolution profile of the testing system with 
respect to the corresponding standard system, were found all within the required FDA 
range. It should be noticed that in Run 2, both f1 and f2 were very close to the FDA limit 












































































Table 3.2  Statistical Values of Three Runs with Position 1 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.005823   9.108 63.266 
Run2 0.0001066 14.834 56.342 
Run3 0.004491   6.687 72.925 
Average  10.209 64.178 
 
3.1.3 Dissolution Profiles for 10° Off-Center Tablets (Positions 2, 3, 4, and 5) 
The dissolution profiles for 10° positioned Prednisone tablets were obtained using both 
the testing system and the standard system. The results from four positions on the 10° 
off-center circle i.e., Positions 2, 3, 4, and 5 in Figure 2.6 (a) are presented in Figure 3.3, 
3.4, 3.5, 3.6, respectively. The corresponding statistics are presented in Table 3.3, 3.4, 3.5, 
3.6, respectively, and the detailed data are shown in Tables C.4 to C.15 in Appendix C. 
The tendency for the testing system to generate higher dissolution profiles than 
the standard system was found in all 10° off-center positions. The differences between 
the profiles from the two systems were consistent. On the other hand, the extents of 
differences were not consistent among the four positions. The most significant difference 
was found at Position 5, while the least significant one at Position 3.  
Paired t-test, f1 and f2 calculation confirmed this observation. The probabilities of 
the profiles being the same were below the significant level of 0.05 for all runs. On the 
other hand, f1 and f2 values indicated that the differences for Position 5 were the largest 
and those for Position 3 were the smallest. In Run 3 in Position 5, both f1 and f2 went out 







































































































































































































































































































Table 3.3  Statistical Values of Three Runs with Position 2 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 5.491E-06 13.239 55.563 
Run2 0.01079   4.721 74.536 
Run3 0.0003098 14.723 51.607 
Average  10.894 60.569 
 
Table 3.4  Statistical Values of Three Runs with Position 3 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.019365388   2.320 84.399 
Run2 3.214E-05 11.307 56.816 
Run3 0.004762   8.352 62.209 
Average    7.326 67.808 
 
Table 3.5  Statistical Values of Three Runs with Position 4 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 6.599E-05 10.263 60.979 
Run2 9.038E-08 11.908 58.175 
Run3 8.640E-08   8.131 64.848 
Average  10.101 61.334 
 
Table 3.6  Statistical Values of Three Runs with Position 5 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 1.835E-07 14.685 53.036 
Run2 1.293E-05 12.778 57.119 
Run3 0.001954 18.551 47.938 





3.1.4 Dissolution Profiles for 20° Off-Center Tablets (Positions 6, 7, 8, and 9) 
The dissolution profiles for the 20° off-center Prednisone tablets were obtained using 
both the testing system and the standard system. The results for the tablets at four 
positions on the 20° off-center circle, i.e.,, for Positions 2, 3, 4, and 5 in Figure 2.6 (a), 
are presented in Figure 3.7, 3.8, 3.9, 3.10, respectively. The statistics are presented in 
Tables 3.7, 3.8, 3.9, and 3.10 respectively. The detailed data obtained in this study are 
shown in Tables C.16 to C.27 in Appendix C.  
The difference between dissolution the profiles for the testing system and those 
for the standard system could still be easily recognized in Position 9, while the 
differences in Positions 6, 7 and 8 were much less pronounced. In some runs in Position 7 
and Position 8, the profiles from the testing system were almost the same or even lower 
than the standard system.  
The results of the paired t-test confirmed this observation. The T-values in 
Position 8 were much lower than the significant level of 0.05, while larger values were 
found in other positions. Run 1 in Position 6, Run 2 and Run 3 in Position 7 and Run 2 in 
Position 8 had T-values larger than 0.05, indicating a higher similarity between the 
profiles in the testing system and those in the standard system. Also, the f1 values were 
highest and f2 values were lowest for Position 8, suggesting the largest differences in 






































































































































































































































































































Table 3.7  Statistical Values of Three Runs with Position 6 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.07142 2.965 76.814 
Run2 0.0002974 5.776 67.902 
Run3 0.003185 4.966 69.566 
Average  4.569 71.427 
 
Table 3.8  Statistical Values of Three Runs with Position 7 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.0003626 3.854 76.241 
Run2 0.08837 3.404 75.494 
Run3 0.05582 5.651 65.872 
Average  4.303 72.536 
 
Table 3.9  Statistical Values of Three Runs with Position 8 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.004357 4.215 76.121 
Run2 0.8734 1.996 86.947 
Run3 7.659E-06 5.539 72.884 
Average  3.917 78.651 
 
Table 3.10  Statistical Values of Three Runs with Position 9 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 4.266E-06 10.778 59.650 
Run2 0.0005785 9.266 61.419 
Run3 0.0001198 11.435 57.574 







3.2 Results of PIV Measurement 
3.2.1 Velocity Vectors 
Figure 3.11 and Figure 3.12 show the velocity vectors map in the standard system and for 
all four sections of the testing system. The vectors in each of the images are scaled with 
the same scale factor according to their magnitudes. The vectors are color-coded in order 
of increasing velocity magnitude. The vectors with the lowest velocities are plotted in 
dark blue, followed by light blue, green, yellow, orange and red, which represents the 
highest velocities.  
The overall flow patterns in all vector maps were similar. The weak, impeller-
generated upward and downward flows impacted the vessel wall, forming recirculation 
loops above and below the impeller. Above the impeller, the circulation loops were 
dominated by axial velocities. Two regions can be identified below the impeller: the first 
region is the outer region characterized by recirculation loops formed by the downwards 
flow produced by the agitation of the impeller and the vessel wall. The second region is 
the inner region just below the shaft at the center of the vessel bottom. This region was 
not penetrated by the recirculation loops of the first region, and the flow in this region 
was very weak. The flow patterns in the standard system were in agreement with those 
obtained in previous studies (Baxter et al., 2005; Bai and Armenante, 2009), and 
therefore were considered to be validated. 
Despite the similarity between figures, two major differences can be observed. 
Firstly, in Section 2-6, the recirculation loop above the impeller became more intense, 
especially in the region where the probe was located. In the other sections in the testing 





the probe, although not significantly. Secondly, the flow velocities below the shaft, which 
is the most important region in the vessel since this is where the tablets would stay in 
actual dissolution tests, were strengthened in Section 2-6 and Section 5-9. Larger radial 
velocities and more defined and stronger circulations could be found. In contrast, in 
Section 3-7 and Section 4-8, the velocities in this region remained the same as those in 
the standard system, or even smaller.  
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3.2.2 Velocity Profiles on Iso-Surfaces 
Figures 3.13 through 3.18 show, respectively, the radial and axial velocity profiles on the 
nine iso-surfaces selected in Section 2.2.2. In these figures, the ordinates represent the 
normalized fluid velocity U/Utip (scaled by the impeller tip speed, Utip=0.197 mm/s) and 
the abscissas represent the normalized radial position R/R0 (scaled using the vessel radius, 
R0=50.08 mm). The centrifugal radial velocity and the upwards axial velocity were 
defined as positive velocity. It should be remarked that the scales in these figures are 
different. 
3.2.2.1 Reproducibility of PIV Measurements.  In order to determine the 
reproducibility of the PIV measurement and to determine the suitability of the instrument 
to detect differences between velocities in the standard system and in the testing system, 
5 identical experiments with the standard system alone were conducted. The standard 
deviation for each data point was calculated and shown in the figures of velocity profiles 
in next three sections as error bars on data points for the standard system. The average 
standard deviations in three regions, i.e., below the impeller, around the impeller and 
above the impeller, are presented in Table 3.11.  
The PIV measurements were found very reproducible in the regions below and 
above the impeller, while a slightly larger error was found for the velocities around the 
impeller, because the velocities in this region were affected by the presence of the 
impeller, therefore the velocities were faster and more turbulent, causing more 
inconsistency in the velocity data. In further measurements, if the differences in velocities 





than one standard deviation of that data point, i.e., out of the range of the error bar, the 
differences were attributed to hydrodynamic effects generated by the fiber optic probe. 
Table 3.11  Average Standard Deviations of PIV Measurements in Three Regions for the 
Standard System 
Region Iso-Surfaces Average Standard Deviation 
Above the Impeller Z=75 mm, 61 mm 0.002398 
Around the Impeller Z=44 mm, 35 mm, 25 mm 0.004368 
Below the Impeller Z=20 mm, 15 mm, 10 mm 
5 mm 
0.001962 
Overall Average 0.002545 
 
3.2.2.1 Velocity Profiles above the Impeller. Figure 3.13 and Figure 3.14 show, 
respectively, the radial and axial velocity profiles on the iso-surfaces above the impeller, 
i.e., Z=75 mm and 61 mm. 
The differences of the velocities profiles between different systems can be easily 
observed in this region. Specifically, in the area where the probe was located, i.e., 
0.4<R/R0<0.7 in Section 2-6, the impact of the probe was most pronounced. Significant 
differences were shown in both radial and axial velocities and on both Z=61 mm and 
Z=75 mm. Also the impact of the probe continued in the region downstream of the probe, 
i.e., Section 5-9, and as well in Section 4-8. On the other hand, in Section 3-7, from 
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Figure 3.14  PIV measurements for axial velocities on iso-surfaces above the impeller. 
 
3.2.2.2 Velocity Profiles around the Impeller.  Figure 3.15 and Figure 3.16 show, 
respectively, the radial and axial velocity profiles on the iso-surfaces around the impeller, 
i.e., Z=44 mm, 35 mm and 25 mm. 
A larger average standard deviation in this region was obtained (Table 3.11). In 
the figures, although the differences between runs were found to larger, most data points 
were within the error range indicated by the error bars. However, several differences 
cannot be attributed to experimental error. On iso-surface Z=25 mm, Section 2-6 had 
lower radial velocities near the vessel wall (R/R0>0.7). On iso-surface Z=35 mm, where 
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velocities compared to the standard system, indicating that the flows were stronger in this 
zone. 
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3.2.2.3 Velocity Profiles below the Impeller.  Figure 3.17 and Figure 3.18 show, 
respectively, the radial and axial  velocity profiles on iso-surfaces below the impeller, i.e., 
Z=20 mm, 15 mm, 10 mm and 5 mm. 
In general, the differences between the velocities were not significant in this 
region. The largest differences in both radial and axial velocities were found in the 
upward recirculation zone, i.e., 0.5<R/R0<0.6 for Z=20 mm, 0.4<R/R0<0.5 for Z=15 mm, 
0.5<R/R0<0.6 for Z=10 mm, and 0.3<R/R0<0.4 for Z=5 mm, and the differences in this 
zone were obtained for all four sections in the testing system. Also slightly higher radial 
velocities in Section 2-6 and Section 5-9 were found in the low velocity zone below the 
shaft (R/R0<0.2 for all four iso-surfaces), which supported the measurement of velocity 
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3.2.3 Sums of Squared Deviations of the Velocity Profiles 
The sums of squared deviation (S value) were calculated for each of the three regions, as 
described in Section 2.2.2. The results are shown in Table 3.12. 
Among the four sections in the testing system, the velocities in Section 2-6 had 
largest total deviation compared to those in the standard system, due to the significant 
differences above the impeller where the probe was inserted. This was followed by 
Section 5-9, where the largest difference can be found in the region below the impeller. 
The deviations around the impeller were similar for all four sections, indicating again the 
flow in the region wa dominated by agitation, which was consistent with studies. 
Table 3.12  Sums of Squared Deviations  
Section Section 2-6 Section 3-7 Section 4-8 Section 5-9 
Above the Impeller 0.028667 0.012550 0.008817 0.013530 
Around the Impeller 0.008852 0.007994 0.007503 0.007673 
Below the Impeller 0.010987 0.008816 0.008272 0.011343 








CHAPTER 4  
DISCUSSION 
4.1 Dissolution Tests 
The results of the experiments presented in Chapter 3 Section 3.1 show that the 
dissolution rates in the testing system were slightly higher than those in the standard 
system. Even though the differences between the dissolution profiles were not typically 
too large, they could nevertheless be observed in most runs, regardless of the positions of 
the tablets. For the majority of the runs, the Student’s t-test values were lower than the 
significant level of 0.05 by one or more order of magnitudes, indicating that the two 
samples obtained with and without the probe were significantly unlikely to come from 
the same population, i.e., the testing system and the standard system generated 
statistically different dissolution results. On the other hand, the similarity factor f1 and 
difference factor f2 for most runs were within the acceptable ranges of, respectively, 
0<f1<15 and 50<f2<150, as required by the FDA, which indicated that the differences 
were not significant enough to fail the dissolution test. Therefore, the results showed that 
the fiber optic probe in the system generated a small hydrodynamic effect that increased 
the dissolution rate of Prednisone tablets. The effect itself was not significant enough to 
cause failure of the test according to FDA requirement of f1 and f2. However, in the 
industrial practice, this effect would reduce the tolerance of the dissolution test.  For 
example, a tablet that intrinsically dissolves slightly faster than what prescribed according 
to the standard specifications (but still within the acceptable dissolution testing 





present, and fail the test because of the hydrodynamic effects introduced by the fiber 
optic probe. 
Also, the impact of the hydrodynamic effect was found to be dependent on tablet 
location. Among both 10° off-center positions and 20° off-center positions, the positions 
where tablets were fixed at downstream region of the probe in agitation flow, i.e., 
Position 5 and 9, tented to generate more significant dissolution profiles differences 
between the two systems. This trend was also found, though less significantly, in the 
positions right below the probe, i.e., Position 2 and 6. Compared to other positions, 
Position 2, 5 and 9 had higher f1 and lower f2 values. In some individual runs, they even 
fell out of requirement range and failed the dissolution tests. The comparisons are shown 
in Table 4.1. The hydrodynamic effects were more pronounced in the zone where the 
probe was located and in the region downstream of the probe. This suggests that the 
probe generates a “baffle effect” in the vessel.  As a result, the Prednisone tablets 
experience a stronger and more turbulent flow than before, hence dissolve faster than 
tablets at other positions. The flow perturbation was then diluted by the agitation flow, 
resulted in less significant difference in dissolution profiles of tablets at other positions.  
Lastly, by comparing the result for tablet positions on different circles but in the 
same radial direction, i.e., Position 2 vs. Position 6, Position 3 vs. Position 7, etc., it can 
be found that 10° off-center positions tented to have larger dissolution profile differences 
between the two systems. This implies that the hydrodynamic effect was also differently 
pronounced at different off-center locations, in particular, more pronounced when the 






Table 4.1  Average f1 and f2 Values of Dissolution Profiles for Each Tablet Position  
 Position Similarity factor (f1) Difference factor (f2) 
Centered 1 10.209 64.178 
10° off-
center 
2 10.894 60.569 
3   7.326 67.808 
4 10.101 61.334 
5 15.338 52.697 
20° off-
center 
6   4.569 71.427 
7   4.303 72.536 
8   3.917 78.651 
9 10.493 59.547 
 
4.2 PIV Measurements 
The PIV measurements were consistent with the results from experimental dissolution 
tests, and showed that the hydrodynamics inside the dissolution vessel was slightly 
affected by the introduction of the fiber optic probe. According to the velocity vector 
maps, the general flow pattern in the vessel remained similar in all four sections in the 
testing system, and it consisted of two recirculation loops and a low-velocity region 
below the shaft. On the other hand, perturbation in the flow caused by the probe were 
found above the impeller in Section 2-6, where the probe was located, confirming that the 
probe did generate a “baffle effect” altering the flow. Also, slight increases in the 
velocities can be found in the low velocity region in Section 2-6 and Section 5-9. These 
increases, though minor, may be responsible for a far more significant increase in the 
dissolution rate of the tablets fixed in those positions, since tablets would directly 





Further quantitative study on the nine iso-surfaces selected showed in detail the 
differences in the velocity profiles between the standard system and the testing system, 
and between different sections in the testing system.  
In the region above the impeller, the most significant difference was observed in 
Section 2-6, and this was in agreement with the observation from the velocity vector 
maps. The S values in this region showed the results of the “baffle effect”. The probe 
disturbed the flow going through, generated the largest deviation from the standard 
system in Section 2-6, and then this flow perturbation was diluted and weakened 
downstream through Section 5-9, Section 3-7 and Section 4-8, in which gradually smaller 
S values were found.  
In the region around the impeller, despite the slightly larger variation in velocity 
magnitude due to more turbulent flows, the S values were similar for all sections, 
indicating that the introduction of the probe did not affect flows in this region, which 
remained dominated by the impeller. 
The region below the impeller was more carefully studied with four iso-surfaces 
selected, since the dissolution rate of the tablet was expected to be more sensitive to the 
flow velocity it experienced directly in this region. Section 5-9 was found to have the 
largest S value, which coincided with the faster dissolution rates of tablets in Position 5 
and Position 9. This can be explained that the perturbation generated by the probe above 
the impeller which reached the region below the impeller at a location further 
downstream of the probe. Although the perturbation may die down along the 
recirculation pattern, its effect could still be noticed, especially in contrast with the low 





pronounced for tablets placed 10° off-center positions than 20° off-center. The central 
and 10° off-center tablet positions were within or partially within the low velocity region 
under the impeller, while the 20° positions were within the upwards recirculation region. 
Therefore, the baseline velocities were much lower in central and 10° off-center positions. 
As a result, any velocity perturbation in this region was more significant, and greater 






CHAPTER 5  
CONCLUSIONS 
 
The hydrodynamic effects of the arch-shaped fiber optic probe in USP Dissolution 
Testing Apparatus 2 were determined by experimentally comparing the dissolution 
profiles obtained in the testing system with those in the standard system, and by 
determining the flow velocities in the two systems via PIV.  
Several conclusions can be drawn from this study. The arch shaped fiber optic 
probe, inserted in the USP-specified sampling zone in the USP Apparatus 2, did have a 
baffling effect on the hydrodynamics in the dissolution vessel. This effect resulted in a 
change in the velocities in the fluid flow, and therefore in a change in the dissolution rate 
of the testing tablet. The baffle effect was observed mainly in the region where the probe 
was inserted. The flow perturbation that it generated became gradually weaker 
downstream of the agitation path. This perturbation was also found to reach the region 
below the impeller and to change the velocity profile there. The effect was most 
pronounced downstream of the probe within the low velocity region right below the shaft, 
and this resulted in the most significant difference in dissolution profiles when the tablets 
were fixed at positions that were downstream of the probe and within the low velocity 
region.  
On the other hand, the hydrodynamic effect generated by the probe was not 
particularly strong. In most dissolution testing runs, the changes in dissolution profile 





The PIV measurements additionally show that the baffle effect was not strong 
enough to break the overall flow pattern, or to affect the region around the impeller, 
which was dominated by the agitation flow.  
In summary, the hydrodynamic effects generated by the arch-shaped fiber optic 
probe are real and observable, resulting in slightly modification of the fluid flow in the 
dissolution vessel and therefore in detectable differences in the dissolution profiles. 







DERIVATION OF EQUATION 2.1 
In this Appendix, Equation 2.1 in Section 2.1.4 was derived based on the mass balance in 
the dissolution system. 
Table A.1  Medium volume change in dissolution tests 
 Initial 
System 





















































The drug release ratio needed to be determined: 
   Dissolved D
Tablet T
m t m tmassof drug insolutionat t
initial massof drug in tablet m m
 
 
i.e., the amount of drug in solution at any time t out of the total initial amount of 
drug in the tablet. 
The initial volume of solution (medium) is V, and each sample has a volume 











In general, at any time t just after taking a sample, the mass balance for the drug 
removed from the tablet (and transferred to the solution) gives: 
 
 
    
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In the presented system, the tablet was dropped in the medium at t=to, the 
agitation was immediately started, and a sample was immediately taken (at t=to=0, 
corresponding to the initial zeroth sample).  This means that for t=to (@ t=0) i.e., after the 
tablet was dropped and the initial sample was taken (and found to have C=C0), the above 
mass balance gives: 
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For t=t1 (corresponding to a sample concentration C=C1) the mass balance gives: 
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For t=t2 (corresponding to a sample concentration C=C2): 
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For t=ti (corresponding to a sample concentration C=Ci): 
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For t=tn (corresponding to a sample concentration C=Cn): 
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Hence, for t=tn (corresponding to a sample concentration C=Cn): 
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Remark: in this study a sample was initially taken at t=to=0 (zeroth sample). This 
means that the 10
th
 sample (including the initial one) corresponds to n=9 (not n=10), i.e., 
n=0, 1, 2, 3, 4, 5, 6, 7, 8, and 9 (10 samples taken every 5 minutes, starting at time t=to=0 






DISSOLUTION PROFILES USING CONCENTRATION RATIO VS. TIME 
In this Appendix, dissolution profiles of Prednisone in both the standard system and the 
testing system are plotted as concentration ratio C(tn)/C* vs. time in Figure B.1 to B.9. 

























































































































































































































































































































































































































































































































































































































Table B.1  Statistical Values of Three Runs with Position 1 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
 Run1 0.009405 9.370 61.537 
Run2 0.000149 14.921 54.870 
Run3 0.004398 6.700 71.720 
Average  9.727 62.758 
 
Table B.2  Statistical Values of Three Runs with Position 2 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 6.67E-06 13.038 54.723 
Run2 0.007478 5.109 72.034 
Run3 0.000660 13.775 51.404 
Average  10.394 58.962 
 
Table B.3  Statistical Values of Three Runs with Position 3 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.02692 2.339 54.723 
Run2 9.62E-05 10.568 72.034 
Run3 0.004842 8.629 51.404 
Average  5.283 71.049 
 
Table B.4  Statistical Values of Three Runs with Position 4 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.000672 9.586 60.949 
Run2 5.90E-06 11.316 58.095 
Run3 0.000348 8.079 63.942 







Table B.5  Statistical Values of Three Runs with Position 5 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 2.71E-07 14.682 52.009 
Run2 2.21E-05 12.565 56.245 
Run3 0.00199 19.270 46.020 
Average  15.213 51.739 
 
Table B.6 Statistical Values of Three Runs with Position 6 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.07903 3.162 74.030 
Run2 0.000500 5.590 67.359 
Run3 0.007182 4.665 68.815 
Average  4.255 73.399 
 
Table B.7 Statistical Values of Three Runs with Position 7 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.000411 3.956 74.675 
Run2 0.1397 3.412 74.399 
Run3 0.05833 5.948 63.676 
Average  3.342 76.518 
 
Table B.8 Statistical Values of Three Runs with Position 8 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 0.003846 4.452 74.115 
Run2 0.8653 2.069 85.805 
Run3 1.14E-05 5.624 71.563 








Table B.9 Statistical Values of Three Runs with Position 9 Tablets 
 Paired T-test (T) Similarity factor (f1) Difference factor (f2) 
Run1 4.98E-06 10.890 58.449 
Run2 0.003039 9.589 59.729 
Run3 0.000595 11.588 56.317 






TABLES OF DISSOLUTION TESTING RESULTS 
Dissolution results of Prednisone in both the standard system and the testing system are 
presented in detail in this Appendix.  
Table C.1  Dissolution Profile of Prednisone in Run 1 at Position 1 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.072 0.00058 2.896 0.123 0.00191 9.552 
5 0.211 0.00421 20.673 0.238 0.00491 24.259 
10 0.321 0.00708 34.446 0.315 0.00692 33.899 
15 0.379 0.00859 41.542 0.409 0.00937 45.416 
20 0.424 0.00977 46.917 0.453 0.01052 50.670 
25 0.466 0.01086 51.811 0.491 0.01151 55.094 
30 0.546 0.01295 60.948 0.540 0.01279 60.671 
35 0.521 0.01230 58.066 0.600 0.01436 67.339 
40 0.544 0.01290 60.519 0.607 0.01454 68.017 






Table C.2  Dissolution Profile of Prednisone in Run 2 at Position 1 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.080 0.00079 3.94 0.079 0.00076 3.810 
5 0.168 0.00308 15.194 0.186 0.00355 17.494 
10 0.283 0.00609 29.597 0.315 0.00692 33.649 
15 0.354 0.00794 38.290 0.391 0.00891 42.953 
20 0.417 0.00958 45.825 0.468 0.01091 52.166 
25 0.467 0.01089 51.656 0.524 0.01237 58.695 
30 0.497 0.01167 55.046 0.565 0.01345 63.340 
35 0.518 0.01222 57.336 0.618 0.01483 69.210 
40 0.548 0.01300 60.549 0.625 0.01501 69.879 
45 0.574 0.01368 63.242 0.638 0.01535 71.166 
 
Table C.3  Dissolution Profile of Prednisone in Run 3 at Position 1 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.068 0.00047 2.374 0.084 0.00089 4.462 
5 0.183 0.00348 17.081 0.166 0.00303 14.949 
10 0.283 0.00609 29.603 0.290 0.00627 30.479 
15 0.364 0.00820 39.523 0.391 0.00891 42.852 
20 0.421 0.00969 46.337 0.454 0.01055 50.382 
25 0.458 0.01065 50.640 0.494 0.01159 55.033 
30 0.524 0.01238 58.167 0.548 0.01300 61.175 
35 0.552 0.01311 61.235 0.580 0.01384 64.690 
40 0.554 0.01316 61.369 0.582 0.01389 64.819 






Table C.4  Dissolution Profile of Prednisone in Run 1 at Position 2 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.081 0.00081 4.071 0.076 0.00068 3.418 
5 0.235 0.00483 23.766 0.254 0.00533 26.182 
10 0.345 0.00771 37.538 0.403 0.00922 44.840 
15 0.430 0.00992 47.946 0.488 0.01144 55.242 
20 0.480 0.01123 53.915 0.557 0.01324 63.487 
25 0.533 0.01261 60.096 0.598 0.01431 68.248 
30 0.577 0.01376 65.089 0.643 0.01548 73.350 
35 0.607 0.01454 68.382 0.683 0.01653 77.758 
40 0.648 0.01561 72.790 0.708 0.01718 80.401 
45 0.666 0.01608 74.611 0.718 0.01744 81.362 
 
Table C.5  Dissolution Profile of Prednisone in Run 2 at Position 2 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.141 0.00238 11.901 0.082 0.00084 4.201 
5 0.264 0.00559 27.631 0.251 0.00525 25.814 
10 0.371 0.00838 41.030 0.379 0.00859 41.841 
15 0.431 0.00995 48.372 0.462 0.01076 52.001 
20 0.522 0.01232 59.270 0.524 0.01238 59.409 
25 0.546 0.01295 62.042 0.584 0.01394 66.406 
30 0.584 0.01394 66.351 0.615 0.01475 69.900 
35 0.614 0.01473 69.651 0.643 0.01548 72.965 
40 0.641 0.01543 72.531 0.667 0.01611 75.507 






Table C.6  Dissolution Profile of Prednisone in Run 3 at Position 2 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.090 0.00105 5.245 0.106 0.00147 7.333 
5 0.253 0.00530 26.091 0.295 0.00640 31.504 
10 0.330 0.00731 35.729 0.409 0.00938 45.776 
15 0.414 0.00951 46.017 0.555 0.01319 63.664 
20 0.495 0.01162 55.711 0.578 0.01379 66.380 
25 0.540 0.01279 60.949 0.607 0.01454 69.735 
30 0.584 0.01394 65.941 0.639 0.01538 73.351 
35 0.622 0.01493 70.131 0.666 0.01608 76.310 
40 0.659 0.01590 74.096 0.687 0.01663 78.530 
45 0.682 0.01650 76.449 0.712 0.01728 81.113 
 
Table  C.7 Dissolution Profile of Prednisone in Run 1 at Position 3 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.088 0.00100 4.984 0.112 0.00162 8.116 
5 0.283 0.00609 29.923 0.268 0.00569 28.067 
10 0.418 0.00961 46.825 0.408 0.00935 45.598 
15 0.514 0.01212 58.577 0.485 0.01136 55.021 
20 0.565 0.01345 64.660 0.545 0.01292 62.189 
25 0.618 0.01483 70.833 0.628 0.01509 71.889 
30 0.661 0.01595 75.705 0.649 0.01564 74.229 
35 0.690 0.01671 78.878 0.686 0.01661 78.302 
40 0.708 0.01718 80.758 0.707 0.01715 80.510 






Table C.8  Dissolution Profile of Prednisone in Run 2 at Position 3 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.090 0.00105 5.245 0.087 0.00097 4.853 
5 0.238 0.00491 24.173 0.310 0.00679 33.373 
10 0.359 0.00807 39.324 0.429 0.00990 48.269 
15 0.459 0.01068 51.570 0.528 0.01248 60.389 
20 0.529 0.01251 59.938 0.589 0.01407 67.673 
25 0.576 0.01373 65.406 0.648 0.01561 74.549 
30 0.621 0.01491 70.5089 0.669 0.01616 76.890 
35 0.676 0.01634 76.601 0.700 0.01697 80.291 
40 0.684 0.01655 77.375 0.716 0.01739 81.954 
45 0.716 0.01738 80.692 0.735 0.01789 83.887 
 
Table C.9  Dissolution Profile of Prednisone in Run 3 at Position3 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.09 0.00105 5.245 0.084 0.00089 4.462 
5 0.294 0.00637 31.334 0.279 0.00598 29.401 
10 0.386 0.00877 42.849 0.409 0.00937 45.677 
15 0.474 0.01107 53.624 0.539 0.01277 61.599 
20 0.557 0.01324 63.554 0.554 0.01316 63.356 
25 0.555 0.01319 63.267 0.607 0.01454 69.532 
30 0.581 0.01386 66.199 0.64 0.01540 73.258 
35 0.616 0.01478 70.065 0.674 0.01629 76.999 
40 0.647 0.01559 73.387 0.69 0.01671 78.663 






Table C.10  Dissolution Profile of Prednisone in Run 1 at Position 4 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.100 0.00131 6.550  0.094  0.00115  5.767  
5 0.190 0.00366 18.060  0.246  0.00512  25.206  
10 0.313 0.00687 33.465  0.389  0.00885  43.113  
15 0.412 0.00945 45.592  0.476  0.01112  53.763  
20 0.491 0.01151 55.043  0.528  0.01248  59.969  
25 0.538 0.01274 60.512  0.570  0.01358  64.853  
30 0.573 0.01365 64.468  0.609  0.01459  69.271  
35 0.609 0.01459 68.432  0.637  0.01532  72.339  
40 0.625 0.01501 70.095  0.653  0.01574  74.007  
45 0.651 0.01569 72.778  0.673  0.01626  76.054  
 
Table C.11  Dissolution Profile of Prednisone in Run 2 at Position 4 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.101 0.00134  6.681 0.111 0.00160  7.986 
5 0.212 0.00423  20.876 0.279 0.00598  29.471 
10 0.352 0.00789  38.41 0.413 0.00948  46.25 
15 0.438 0.01013  48.939 0.494 0.01159  56.163 
20 0.501 0.01178  56.468 0.548 0.01300  62.61 
25 0.54 0.01279  61 0.596 0.01426  68.2 
30 0.583 0.01392  65.879 0.63 0.01514  72.043 
35 0.612 0.01467  69.06 0.658 0.01587  75.112 
40 0.638 0.01535  71.824 0.686 0.01661  78.096 






Table C.12  Dissolution Profile of Prednisone in Run 3 at Position 4 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.105  0.00144  7.203  0.088  0.00100  4.984  
5 0.257  0.00541  26.642  0.292  0.00632  31.074  
10 0.398  0.00909  44.298  0.436  0.01008  49.103  
15 0.478  0.01118  54.089  0.515  0.01214  58.768  
20 0.541  0.01282  61.617  0.570  0.01358  65.333  
25 0.572  0.01363  65.208  0.609  0.01460  69.862  
30 0.599  0.01433  68.250  0.639  0.01538  73.245  
35 0.626  0.01504  71.212  0.676  0.01634  77.325  
40 0.644  0.01551  73.106  0.695  0.01684  79.320  
45 0.678  0.01640  76.655  0.712  0.01728  81.041  
 
Table C.13  Dissolution Profile of Prednisone in Run 1 at Position 5 
Time 
(min) 











0 0.141  0.00238  11.901  0.109  0.00155  7.725  
5 0.264  0.00559  27.631  0.309  0.00677  33.303  
10 0.371  0.00838  41.030  0.438  0.01013  49.453  
15 0.431  0.00995  48.372  0.503  0.01183  57.403  
20 0.522  0.01232  59.270  0.570  0.01358  65.412  
25 0.546  0.01295  62.042  0.619  0.01486  71.117  
30 0.584  0.01394  66.351  0.659  0.01590  75.648  
35 0.614  0.01473  69.651  0.696  0.01687  79.723  
40 0.641  0.01543  72.531  0.719  0.01747  82.152  






Table C.14  Dissolution Profile of Prednisone in Run 2 at Position 5 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.089  0.00102  5.115  0.095  0.00118  5.898  
5 0.203  0.00400  19.694  0.257  0.00541  26.616  
10 0.355  0.00797  38.731  0.403  0.00922  44.898  
15 0.430  0.00992  47.909  0.445  0.01032  50.026  
20 0.487  0.01141  54.718  0.550  0.01306  62.602  
25 0.505  0.01188  56.786  0.552  0.01311  62.783  
30 0.532  0.01259  59.834  0.595  0.01423  67.666  
35 0.560  0.01332  62.915  0.645  0.01554  73.208  
40 0.615  0.01475  68.870  0.672  0.01624  76.079  
45 0.645  0.01554  71.983  0.701  0.01700  79.080  
 
Table C.15  Dissolution Profile of Prednisone in Run 3 at Position 5 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.098  0.00126  6.289  0.100  0.00131  6.550  
5 0.238  0.00491  24.194  0.224  0.00455  22.408  
10 0.359  0.00807  39.345  0.365  0.00823  40.066  
15 0.414  0.00951  46.072  0.476  0.01112  53.661  
20 0.457  0.01063  51.205  0.530  0.01253  60.106  
25 0.495  0.01162  55.630  0.587  0.01402  66.749  
30 0.523  0.01235  58.796  0.630  0.01514  71.620  
35 0.548  0.01300  61.543  0.676  0.01634  76.701  
40 0.582  0.01389  65.200  0.703  0.01705  79.560  






Table C.16  Dissolution Profile of Prednisone in Run 1 at Position 6 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.108  0.00152  7.594  0.100  0.00131  6.550  
5 0.312  0.00684  33.684  0.305  0.00666  32.767  
10 0.447  0.01037  50.586  0.454  0.01055  51.423  
15 0.515  0.01214  58.902  0.541  0.01282  62.069  
20 0.608  0.01457  70.032  0.600  0.01436  69.112  
25 0.624  0.01499  71.855  0.649  0.01564  74.814  
30 0.675  0.01632  77.650  0.684  0.01655  78.765  
35 0.715  0.01736  82.060  0.715  0.01736  82.164  
40 0.726  0.01765  83.171  0.741  0.01804  84.922  
45 0.760  0.01854  86.708  0.819  0.02008  93.163  
 
Table C.17  Dissolution Profile of Prednisone in Run 2 at Position 6 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.148  0.00256  12.814  0.125  0.00196  9.813  
5 0.311  0.00682  33.660  0.368  0.00831  40.890  
10 0.440  0.01018  49.813  0.458  0.01065  52.152  
15 0.523  0.01235  59.972  0.552  0.01311  63.661  
20 0.570  0.01358  65.579  0.617  0.01480  71.427  
25 0.618  0.01483  71.171  0.660  0.01593  76.426  
30 0.672  0.01624  77.313  0.682  0.01650  78.888  
35 0.695  0.01684  79.816  0.712  0.01728  82.183  
40 0.716  0.01739  82.031  0.749  0.01825  86.154  






Table C.18  Dissolution Profile of Prednisone in Run 3 at Position 6 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.089  0.00102  5.115  0.089  0.00102  5.115  
5 0.300  0.00653  32.099  0.315  0.00692  34.018  
10 0.433  0.01000  48.751  0.461  0.01073  52.297  
15 0.513  0.01209  58.539  0.561  0.01334  64.536  
20 0.562  0.01337  64.384  0.592  0.01415  68.215  
25 0.607  0.01454  69.620  0.667  0.01611  76.973  
30 0.642  0.01546  73.577  0.672  0.01624  77.476  
35 0.686  0.01661  78.441  0.686  0.01661  78.972  
40 0.704  0.01707  80.323  0.714  0.01734  81.961  
45 0.739  0.01799  83.967  0.739  0.01799  84.542  
 
Table C.19  Dissolution Profile of Prednisone in Run 1 at Position 7 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.088  0.00100  4.984  0.096  0.00121  6.028  
5 0.292  0.00632  31.074  0.294  0.00637  31.350  
10 0.427  0.00985  47.976  0.414  0.00951  46.373  
15 0.535  0.01266  61.199  0.510  0.01201  58.127  
20 0.592  0.01415  68.000  0.572  0.01363  65.532  
25 0.635  0.01527  72.995  0.614  0.01473  70.413  
30 0.675  0.01632  77.522  0.651  0.01569  74.597  
35 0.702  0.01702  80.470  0.679  0.01642  77.663  
40 0.722  0.01754  82.570  0.695  0.01684  79.328  






Table C.20  Dissolution Profile of Prednisone in Run 2 at Position 7 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.126  0.00199  9.943  0.093  0.00113  5.637  
5 0.287  0.00619  30.533  0.315  0.00692  34.028  
10 0.403  0.00922  45.057  0.441  0.01021  49.802  
15 0.497  0.01167  56.568  0.545  0.01293  62.534  
20 0.553  0.01313  63.255  0.565  0.01345  64.894  
25 0.600  0.01436  68.727  0.604  0.01446  69.428  
30 0.643  0.01548  73.604  0.643  0.01548  73.849  
35 0.689  0.01668  78.690  0.673  0.01627  77.144  
40 0.709  0.01721  80.788  0.699  0.01694  79.911  
45 0.727  0.01768  82.610  0.093  0.01775  83.132  
 
Table C.21  Dissolution Profile of Prednisone in Run 3 at Position 7 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.129  0.00207  10.335  0.102  0.00136  6.811  
5 0.319  0.00703  34.634  0.299  0.00650  32.005  
10 0.417  0.00958  46.901  0.445  0.01032  50.286  
15 0.535  0.01266  61.356  0.539  0.01277  61.791  
20 0.555  0.01319  63.718  0.559  0.01329  64.151  
25 0.645  0.01554  74.244  0.625  0.01501  71.857  
30 0.706  0.01713  81.181  0.626  0.01504  71.908  
35 0.728  0.01770  83.561  0.680  0.01645  77.903  
40 0.733  0.01783  84.010  0.695  0.01684  79.460  






Table C.22  Dissolution Profile of Prednisone in Run 1 at Position 8 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.107  0.00149  7.464  0.087  0.00097  4.854  
5 0.266  0.00564  27.798  0.268  0.00570  28.002  
10 0.436  0.01008  49.087  0.427  0.00985  47.912  
15 0.476  0.01112  53.968  0.500  0.01175  56.840  
20 0.536  0.01269  61.138  0.549  0.01303  62.685  
25 0.571  0.01360  65.203  0.596  0.01426  68.156  
30 0.600  0.01436  68.477  0.634  0.01525  72.458  
35 0.625  0.01501  71.216  0.654  0.01577  74.627  
40 0.650  0.01567  73.880  0.677  0.01637  77.063  
45 0.668  0.01614  75.717  0.700  0.01697  79.429  
 
Table C.23  Dissolution Profile of Prednisone in Run 2 at Position 8 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.112  0.00162  8.116  0.090  0.00105  5.245  
5 0.283  0.00609  29.985  0.309  0.00677  33.253  
10 0.406  0.00930  45.386  0.408  0.00935  45.644  
15 0.479  0.01120  54.319  0.473  0.01105  53.596  
20 0.538  0.01274  61.368  0.520  0.01227  59.206  
25 0.572  0.01363  65.315  0.566  0.01347  64.566  
30 0.592  0.01415  67.555  0.606  0.01452  69.103  
35 0.636  0.01530  72.429  0.629  0.01512  71.615  
40 0.662  0.01598  75.198  0.652  0.01572  74.057  






Table C.24  Dissolution Profile of Prednisone in Run 3 at Position 8 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.106  0.00147  7.333  0.093  0.00113  5.637  
5 0.273  0.00583  28.691  0.291  0.00630  30.959  
10 0.386  0.00878  42.839  0.400  0.00914  44.604  
15 0.455  0.01058  51.282  0.473  0.01105  53.537  
20 0.501  0.01178  56.773  0.527  0.01246  59.986  
25 0.546  0.01295  62.016  0.573  0.01366  65.343  
30 0.583  0.01392  66.210  0.612  0.01467  69.763  
35 0.607  0.01454  68.836  0.646  0.01556  73.507  
40 0.633  0.01522  71.609  0.666  0.01608  75.614  
45 0.660  0.01593  74.408  0.692  0.01676  78.300  
 
Table C.25  Dissolution Profile of Prednisone in Run 1 at Position 9 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.106  0.00147  7.333  0.085  0.00092  4.593  
5 0.285  0.00614  30.225  0.306  0.00669  32.856  
10 0.381  0.00864  42.243  0.413  0.00948  46.250  
15 0.442  0.01024  49.706  0.493  0.01157  56.040  
20 0.496  0.01165  56.160  0.553  0.01313  63.208  
25 0.538  0.01274  61.051  0.592  0.01415  67.739  
30 0.569  0.01355  64.558  0.622  0.01493  71.124  
35 0.591  0.01413  66.963  0.653  0.01574  74.532  
40 0.615  0.01475  69.521  0.676  0.01634  76.970  






Table C.26  Dissolution Profile of Prednisone in Run 2 at Position 9 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.102  0.00136  6.811  0.085  0.00092  4.593  
5 0.289  0.00624  30.726  0.277  0.00593  29.147  
10 0.390  0.00888  43.370  0.423  0.00974  47.428  
15 0.463  0.01078  52.304  0.505  0.01188  57.462  
20 0.520  0.01227  59.115  0.565  0.01345  64.627  
25 0.569  0.01355  64.826  0.611  0.01465  69.977  
30 0.597  0.01428  67.983  0.649  0.01564  74.276  
35 0.625  0.01501  71.056  0.678  0.01640  77.452  
40 0.641  0.01543  72.730  0.711  0.01726  80.979  
45 0.663  0.01600  74.996  0.725  0.01762  82.371  
 
Table C.27  Dissolution Profile of Prednisone in Run 3 at Position 9 
Time 
(min) 
Standard System Testing System 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
UV 
Absorbance 
C (mg/mL) mD/mT (%) 
0 0.095  0.00118  5.898  0.088  0.00100  4.984  
5 0.295  0.00640  31.476  0.292  0.00632  31.074  
10 0.395  0.00901  43.993  0.433  0.01000  48.727  
15 0.450  0.01045  50.719  0.512  0.01206  58.393  
20 0.494  0.01159  55.971  0.553  0.01313  63.277  
25 0.530  0.01253  60.160  0.596  0.01426  68.279  
30 0.575  0.01371  65.277  0.629  0.01512  72.009  
35 0.597  0.01428  67.681  0.659  0.01590  75.304  
40 0.614  0.01473  69.470  0.681  0.01647  77.632  
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